Hematospermia does not increase the risk of prostate cancer detection in prostate biopsy

Background: Studies on the association between hematospermia and prostate cancer are insufficient. The purpose of this study was to determine the prevalence of prostate cancer in patients with hematospermia using large United States population data. Materials and methods: This was a retrospective ob...

Full description

Bibliographic Details
Published in:	Prostate International
Main Authors:	Jae Ryun Park, Sung Hyun Paick, Woo Suk Choi, Aram Kim, Hyeong Gon Kim, Benjamin I. Chung, Hyoung Keun Park
Format:	Article
Language:	English
Published:	Elsevier 2024-09-01
Subjects:	Hematospermia Prostate Prostate biopsy Prostate cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2287888224000357

Similar Items

Etiology and outcome of hematospermia :A prospective study
by: Measar Karim Hadaia
Published: (2023-10-01)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
by: Kwang Suk Lee, et al.
Published: (2017-03-01)

How to avoid prostate biopsy in men with Prostate Image-Reporting and Data System 3 lesion? Development and external validation of new biopsy indication using prostate health index density
by: Jae Yeon Kim, et al.
Published: (2023-09-01)

Association Between Prostate Cancer Detection Rate and Year of Prostate Biopsy
by: Young Jun Uhm, et al.
Published: (2025-02-01)

Does the type of the previous biopsy affect the fusion prostate biopsy results?
by: Gokhan Sonmez, et al.
Published: (2024-09-01)

Ultrasound detection of prostatic calculi as a parameter to predict the appearance of hematospermia after a prostate biopsy
by: Lucio Dell'Atti

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
by: Yong Hyun Park, et al.
Published: (2014-03-01)

Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?
by: Pietro Pepe, et al.
Published: (2015-10-01)

What Should Be the Prostate Specific Antigen Threshold for Prostate Biopsy?
by: Hasan Deliktaş, et al.
Published: (2017-06-01)

A review of transrectal ultrasound guided prostate biopsies: Is there still a role for finger guided prostate biopsies?
by: K.S. Jehle, et al.
Published: (2015-03-01)

Routine systematic prostate biopsies not replaced by magnetic resonance imaging-targeted biopsy
by: David Gómez-Ortiz, et al.
Published: (2022-10-01)

Decision regret after prostate biopsy for prostate cancer diagnosis: a Korean multicenter cohort study
by: Hwanik Kim, et al.
Published: (2024-06-01)

COMPARATIVE EVALUATION OF CURRENT METHODS OF ANESTHESIA IN PERFORMANCE OF TRANSRECTAL PROSTATE BIOPSY
by: M. E. Topuzov, et al.
Published: (2015-10-01)

Advanced prostate cancer diagnosed by bone metastasis biopsy immediately after initial negative prostate biopsy: a case report and literature review
by: Mingwen Liu, et al.
Published: (2024-05-01)

Rebiopsy rate after transperineal or transrectal prostate biopsy
by: Jose L. Marenco Jimenez, et al.
Published: (2021-06-01)

Transrectal ultrasound and needle biopsy of the prostate
by: Tomaž Smrkolj
Published: (2016-01-01)

Comparison of Grading Accuracy of Prostate Cancer in Samples Acquired by a Targeted and Systemic Prostate Biopsy
by: Ivan Pezelj, et al.
Published: (2022-01-01)

Multicentre assessment of transperineal targeted prostate biopsy performed as part of a targeted and systematic biopsy diagnostic strategy in men without previous prostate biopsies
by: Mohammed Sheweita, et al.
Published: (2025-04-01)

Continued administration of antithrombotic agents during transperineal prostate biopsy
by: Toko Asano, et al.
Published: (2015-02-01)

Serum Adipokines as Predictors for the Outcome of Prostate Biopsies at Early Stage Prostate Cancer Diagnosis
by: Ahmad AE, et al.
Published: (2019-11-01)

Enhancing Prostate Cancer Detection Accuracy in Magnetic Resonance Imaging–targeted Prostate Biopsy: Optimizing the Number of Cores Taken
by: Fabio Zattoni, et al.
Published: (2024-08-01)

Impact of Prostate Needle Biopsy on Erectile Function
by: Fatih Yanaral, et al.
Published: (2019-03-01)

Robotic unilateral seminal vesiculectomy for chronic hematospermia
by: Amjad Alwaal, et al.
Published: (2025-05-01)

MR-Guided Targeted Prostate Biopsy from Radiologists’ Perspective
by: So-Yeon Kim, et al.
Published: (2023-11-01)

Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study
by: Antonio Benito Porcaro, et al.
Published: (2015-10-01)

Cognitive Targeted Prostate Biopsy Alone for Diagnosing Clinically Significant Prostate Cancer in Selected Biopsy-Naïve Patients: Results from a Retrospective Pilot Study
by: Michelangelo Olivetta, et al.
Published: (2024-07-01)

Systematic and Targeted Prostate Biopsy: a Five-Year Experience in a High-Volume Center
by: Toni Zekulić, et al.
Published: (2024-01-01)

The carbon footprint of transperineal prostate biopsy
by: Daniel A. Carson, et al.
Published: (2025-08-01)

Prostate biopsy in a rural hospital: Our experience
by: Suresh K Jariwala
Published: (2017-01-01)

Prostatic Inflammation in Prostate Cancer: Protective Effect or Risk Factor?
by: Alessandro Tafuri, et al.
Published: (2021-06-01)

Pelvic mass causing hematospermia: splenosis
by: Yu Jiang, et al.
Published: (2022-11-01)

Value of cognitive fusion targeted and standard systematic transrectal prostate biopsy for prostate cancer diagnosis
by: Lu-Ping Yu, et al.
Published: (2024-09-01)

Impact of Ultrasonographic Findings on Cancer Detection Rate during Magnetic Resonance Image/ Ultrasonography Fusion-Targeted Prostate Biopsy
by: Jong Kil Nam, et al.
Published: (2023-07-01)

Experience in the use of MRI-ultrasound fusion-targeted biopsy of the prostate for the diagnosis of prostate cancer
by: E. S. Nevirovich, et al.
Published: (2018-10-01)

Optimal PSA density threshold for prostate biopsy in benign prostatic obstruction patients with elevated PSA levels but negative MRI findings
by: Yiji Peng, et al.
Published: (2025-03-01)

Percentage of free prostate-specific antigen (PSA) is a useful method in deciding to perform prostate biopsy with higher core numbers in patients with low PSA cut-off values
by: Hasan Yilmaz, et al.
Published: (2015-06-01)

Second to fourth digit ratio: its relationship with core cancer volume and Gleason score in prostate biopsy
by: Jin Kyu Oh, et al.
Published: (2012-10-01)

The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy
by: Ugo Giovanni Falagario, et al.
Published: (2025-01-01)

Hematospermia: norm or pathology? Modern approaches to etiopathogenesis, diagnosis and treatment
by: O. A. Nikiforov, et al.
Published: (2018-06-01)

Repeat prostate biopsies following diagnoses of prostate intraepithelial neoplasia and atypical small gland proliferation
by: Katia R. Leite, et al.
Published: (2005-04-01)